ZBIO: Zenas Corp Sotuvga nisbatan narx
Zenas Biopharma Inc (ZBIO) investorlar va shifokorlar orasida o'z obro'sini jadal mustahkamlamoqda. Autoimmun patologiyalarni davolash uchun diversifikatsiyalashgan loyihalar portfeli risklarni minimallashtiradi, ko'p spesifik antitelalarning ishlab chiqilishi esa ko'p milliard dollarlik bozorlarga kirish imkonini beradi. Baholashning savdo hajmlariga nisbati talab dinamikasini namoyish etadi, bunda 173.30 eng so'nggi darajani ifodalab, aktivning haqiqiy daromadga nisbatan haddan tashqari sotib olinganligi riskini baholashga yordam beradi.
Zenas Corp (ZBIO) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati Zenas Biopharma Inc|ZBIO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati zenasbio.com|ZBIO - Kompaniya qarzlari|Sof aktivlarga qarzlar Zenas Biopharma Inc|ZBIO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Zenas Biopharma|Tezkor likvidlik zenasbio.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
ZBIO - Sof foyda|Kompaniya foydasi prognozi Zenas Biopharma Inc|ZBIO - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Zenas Corp|ZBIO - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Zenas Corp|ZBIO - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun foyda Zenas Biopharma|ZBIO - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi zenasbio.com|ZBIO - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Zenas Biopharma Inc
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:ZBIO, Zenas Biopharma, Inc.
Zenas Biopharma Inc (ZBIO) to'liq geosiyosiy barqarorlik va diversifikatsiya qilingan ta'minot zanjirlari sharoitida immun biologiklarini ishlab chiqadi. P/S trayektoriyasi yillik daromadning bir dollari bozor qiymatini aks ettiradi, bu esa investorlarga joriy savdo uchun to'langan premiumni baholash va bozor siklidagi potentsial o'zgarishdan oldin aktivni baholash cho'qqisida sotib olishdan qochish imkonini beradi.
Zenas Biopharma Inc kimlar bilan raqobatlashadi
argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|P/S multiplikatori IMNM (immunome.com)|Gossamer Bio, Inc. - Narxning daromadga nisbati|KalVista Pharmaceuticals, Inc. - P/S multiplikatori|SEPN (Septerna) - Kapitalizatsiya va daromad nisbati|Pieris Corp (PVLA) - Narxning daromadga nisbati|SVRA - Narx/daromad koeffitsiyenti|RIGL (rigel.com) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANAB (AnaptysBio, Inc.)|P/S multiplikatori ATXS|enGene Holdings Inc (ENGN) - Narx/daromad multiplikatori|P/S multiplikatori RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Narxning sotuvga nisbati|ACRS: Kapitalizatsiyaning daromadga nisbati|KYTX - P/S multiplikatori|TLSA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Cabaletta Bio, Inc|Narxning daromadga nisbati Ventyx Biosciences, Inc|THTX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati AVTX (Avalo Therapeutics, Inc)|Kapitalizatsiyaning daromadga nisbati Eledon Pharmaceuticals ELDN|Narxning daromadga nisbati Agenus, Inc. AGEN|P/S multiplikatori Climb Bio Inc. CLYM|ZURA - Narxning daromadga nisbati|Narxning sotuvga nisbati ATYR|ADAG (Adagene Inc.) - Kapitalizatsiyaning daromadga nisbati|ImageneBio Inc (IMA) - P/S multiplikatori|Narxning daromadga nisbati Shattuck Therapeutics|Kapitalizatsiyaning daromadga nisbati equilliumbio.com (EQ)|P/S multiplikatori CNTB|Narx/daromad koeffitsiyenti Immunic Therapeutics|P/S multiplikatori ATRA (Atara Biotherapeutics, Inc.)|IFRX - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Kapitalizatsiya va daromad nisbati|CELU: P/S multiplikatori|INMB - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Barinthus Biotherapeutics plc|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori
